Adhera Therapeutics, Inc. ATRX
0.00 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
0.0001 Day range 0.0001
0.0001 52-week range 0.0001
- YTD
- 0.00%
- 1 year
- 0.00%
News
defenseworld.net CG Oncology (NASDAQ:CGON) vs. Adhera Therapeutics (OTCMKTS:ATRX) Critical Survey CG Oncology (NASDAQ: CGON - Get Free Report) and Adhera Therapeutics (OTCMKTS:ATRX - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies…
globenewswire.com Manufacturing Commences on Adhera's MLR-1019 for Phase 2a Clinical Trial Treating Parkinson's Disease IP Estate Grows with New Korean Patent Issued
investorplace.com 7 Biotech Penny Stocks With Huge Catalysts Coming in 2022 With a new year fast approaching, these biotech penny stocks may benefit from the shifting winds in the broader healthcare market. The post 7 Biotech Penny Stocks With Huge Catalysts Coming in 2022…
globenewswire.com Adhera Receives European Patent Covering MLR-1019 and Derivatives for Treating Dyskinesias Baton Rouge, LA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, is pleased to announce that a new…
benzinga.com Stocks That Hit 52-Week Highs On Tuesday 
benzinga.com Stocks That Hit 52-Week Lows On Friday